Guided by Evidence: Preparing for ICH M15 and the Next Evolution of Model-Informed Drug Development Guide Guided by Evidence: Preparing for ICH M15 and the Next Evolution of Model-Informed Drug Development Prepare for ICH M15 guideline: Learn how to assess model credibility, align terminology, and strengthen…CertaraFebruary 13, 2026
EMA Policy 0070 Submission Readiness Checklist Guide EMA Policy 0070 Submission Readiness Checklist Use this EMA Policy 0070 Submission Checklist to prepare compliant clinical data packages, manage anonymization…CertaraFebruary 12, 2026
Pediatric Drug Development: From “Wild West” to Model-Informed Confidence Blog Pediatric Drug Development: From “Wild West” to Model-Informed Confidence Model-informed drug development and precision dosing are transforming pediatric programs, from regulatory planning to Bayesian…CertaraFebruary 11, 2026
Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants Publication Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…CertaraFebruary 2, 2026
Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach Press Coverage Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach Explore how a collaborative “sandbox” approach—combining flexible regulation, data modeling, and stakeholder engagement—can transform rare…CertaraJanuary 30, 2026
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients Publication Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…CertaraJanuary 22, 2026
Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy Webinar Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy CertaraJanuary 22, 2026
Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus Blog Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…CertaraJanuary 16, 2026
CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access Webinar CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access CertaraJanuary 14, 2026